Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Ruymann

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Leukemia Research|January 1, 1986
Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non lymphocytic leukemia--a Pediatric Oncology Group StudyH W Findley, C P Steuber, F B Ruymann, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1995
Successful treatment of disseminated central nervous system malignant rhabdoid tumorT A Olson, E Bayar, E Kosnik, et al.
Pediatric Cardiology|January 1, 1982
Cardiomyopathy in a child with hypereosinophilic syndromeT A Olson, R Virmani, R A Ansinelli, et al.
Medical and Pediatric Oncology|January 1, 1988
Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center)F B Ruymann, H R Maddux, A Ragab, et al.
Cancer|June 15, 1982
Soft-tissue sarcoma of the trunk in childhood. Results of the intergroup rhabdomyosarcoma studyR B Raney, A H Ragab, F B Ruymann, et al.
Journal of Clinical Apheresis|January 14, 1999
Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapyA M Rauck, F B Ruymann, K Klopfenstein, et al.
Cancer Clinical Trials|January 1, 1979
Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology GroupR B Raney, E A Gehan, H M Maurer, et al.
Cancer|July 1, 1983
Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group StudyB A Cook, J R Sinnhuber, P J Thomas, et al.
Medical and Pediatric Oncology|September 1, 1997
Undifferentiated sarcomas of children: pathology and clinical behavior--an Intergroup Rhabdomyosarcoma studyB R Pawel, A B Hamoudi, L Asmar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group studyC P Steuber, C Civin, J Krischer, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Leukemia Research|January 1, 1986
Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non lymphocytic leukemia--a Pediatric Oncology Group StudyH W Findley, C P Steuber, F B Ruymann, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1995
Successful treatment of disseminated central nervous system malignant rhabdoid tumorT A Olson, E Bayar, E Kosnik, et al.
Pediatric Cardiology|January 1, 1982
Cardiomyopathy in a child with hypereosinophilic syndromeT A Olson, R Virmani, R A Ansinelli, et al.
Medical and Pediatric Oncology|January 1, 1988
Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center)F B Ruymann, H R Maddux, A Ragab, et al.
Cancer|June 15, 1982
Soft-tissue sarcoma of the trunk in childhood. Results of the intergroup rhabdomyosarcoma studyR B Raney, A H Ragab, F B Ruymann, et al.
Journal of Clinical Apheresis|January 14, 1999
Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapyA M Rauck, F B Ruymann, K Klopfenstein, et al.
Cancer Clinical Trials|January 1, 1979
Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology GroupR B Raney, E A Gehan, H M Maurer, et al.
Cancer|July 1, 1983
Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group StudyB A Cook, J R Sinnhuber, P J Thomas, et al.
Medical and Pediatric Oncology|September 1, 1997
Undifferentiated sarcomas of children: pathology and clinical behavior--an Intergroup Rhabdomyosarcoma studyB R Pawel, A B Hamoudi, L Asmar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group studyC P Steuber, C Civin, J Krischer, et al.
Pageof 6